Pilot trial of Afamelanotide (SCENESSE) in patients with Hailey‐Hailey Disease (HHD, also known as familial benign pemphigus)
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2016
Price : $35 *
At a glance
- Drugs Afamelanotide (Primary)
- Indications Pemphigus
- Focus Therapeutic Use
- Acronyms CUV010
- 18 Jul 2016 Results from this study published in both the New England Journal of Medicine and Photochemisty and Photobiology in 2009, as per Clinuvel Pharmaceuticals media release.
- 02 Dec 2013 New trial record
- 28 Oct 2013 Results published in the Media Release.